226 related articles for article (PubMed ID: 19685054)
1. Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane.
Feng Z; Zhao G; Yu L; Gough D; Howell SB
Cancer Chemother Pharmacol; 2010 Apr; 65(5):923-30. PubMed ID: 19685054
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts.
Wang X; Zhao G; Van S; Jiang N; Yu L; Vera D; Howell SB
Cancer Chemother Pharmacol; 2010 Feb; 65(3):515-26. PubMed ID: 19593566
[TBL] [Abstract][Full Text] [Related]
3. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L
Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment.
Yang D; Van S; Liu J; Wang J; Jiang X; Wang Y; Yu L
Int J Nanomedicine; 2011; 6():2557-66. PubMed ID: 22072890
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and biological evaluation of poly(L-γ-glutamyl-glutamine)- paclitaxel nanoconjugate.
Van S; Das SK; Wang X; Feng Z; Jin Y; Hou Z; Chen F; Pham A; Jiang N; Howell SB; Yu L
Int J Nanomedicine; 2010 Oct; 5():825-37. PubMed ID: 21042550
[TBL] [Abstract][Full Text] [Related]
6. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
[TBL] [Abstract][Full Text] [Related]
7. Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)-paclitaxel nanoparticles.
Yang D; Van S; Jiang X; Yu L
Int J Nanomedicine; 2011 Jan; 6():85-91. PubMed ID: 21289985
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of tLyp-1 with polymeric paclitaxel conjugates: Enhanced intratumoral accumulation and anti-tumor efficacy.
Liu Z; Huang Z; Ci L; Lu L; Liu Z; Yan X; Yan Z; Yu L; Liu Y; Lu W
Pharmazie; 2017 Apr; 72(4):205-208. PubMed ID: 29441988
[TBL] [Abstract][Full Text] [Related]
9. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.
Xiao K; Luo J; Fowler WL; Li Y; Lee JS; Xing L; Cheng RH; Wang L; Lam KS
Biomaterials; 2009 Oct; 30(30):6006-16. PubMed ID: 19660809
[TBL] [Abstract][Full Text] [Related]
10. Effect of molecular weight of PGG-paclitaxel conjugates on in vitro and in vivo efficacy.
Yang D; Liu X; Jiang X; Liu Y; Ying W; Wang H; Bai H; Taylor WD; Wang Y; Clamme JP; Co E; Chivukula P; Tsang KY; Jin Y; Yu L
J Control Release; 2012 Jul; 161(1):124-31. PubMed ID: 22521595
[TBL] [Abstract][Full Text] [Related]
11. A Novel Gd-DTPA-conjugated Poly(L-γ-glutamyl-glutamine)-paclitaxel Polymeric Delivery System for Tumor Theranostics.
Gao L; Zhou J; Yu J; Li Q; Liu X; Sun L; Peng T; Wang J; Zhu J; Sun J; Lu W; Yu L; Yan Z; Wang Y
Sci Rep; 2017 Jun; 7(1):3799. PubMed ID: 28630436
[TBL] [Abstract][Full Text] [Related]
12. Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates.
Luo Z; Yan Z; Jin K; Pang Q; Jiang T; Lu H; Liu X; Pang Z; Yu L; Jiang X
J Colloid Interface Sci; 2017 Mar; 490():783-796. PubMed ID: 27988470
[TBL] [Abstract][Full Text] [Related]
13. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.
Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
Int J Nanomedicine; 2019; 14():6269-6285. PubMed ID: 31496685
[TBL] [Abstract][Full Text] [Related]
16. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
Kinoshita R; Ishima Y; Chuang VTG; Nakamura H; Fang J; Watanabe H; Shimizu T; Okuhira K; Ishida T; Maeda H; Otagiri M; Maruyama T
Biomaterials; 2017 Sep; 140():162-169. PubMed ID: 28651144
[TBL] [Abstract][Full Text] [Related]
17. A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models.
Bhattacharyya J; Bellucci JJ; Weitzhandler I; McDaniel JR; Spasojevic I; Li X; Lin CC; Chi JT; Chilkoti A
Nat Commun; 2015 Aug; 6():7939. PubMed ID: 26239362
[TBL] [Abstract][Full Text] [Related]
18. Albumin-coated nanocrystals for carrier-free delivery of paclitaxel.
Park J; Sun B; Yeo Y
J Control Release; 2017 Oct; 263():90-101. PubMed ID: 28049022
[TBL] [Abstract][Full Text] [Related]
19. Update on nanoparticle albumin-bound paclitaxel.
Socinski M
Clin Adv Hematol Oncol; 2006 Oct; 4(10):745-6. PubMed ID: 17099631
[No Abstract] [Full Text] [Related]
20. Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer.
Yuan H; Guo H; Luan X; He M; Li F; Burnett J; Truchan N; Sun D
Mol Pharm; 2020 Jul; 17(7):2275-2286. PubMed ID: 32485107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
